What does the BRTX Schedule 13G/A amendment report?

The amendment reports that Todd Hale Morrison beneficially owned 0 shares of BioRestorative Therapies common stock as of 02/23/2026. It also states 0.0% ownership and zero voting and dispositive powers.

Who is the filing person on the BRTX amendment?

The filing person is Todd Hale Morrison , a U.S. citizen. The filing lists the reporting person's residence as the address for the principal business office and includes the signature dated 02/23/2026.

What voting and dispositive powers are reported in the filing?

The filing states the reporting person has 0 in sole voting power, 0 shared voting power, 0 sole dispositive power, and 0 shared dispositive power as of 02/23/2026.

What percentage of BRTX is reported as owned by the filer?

The amendment reports the filer beneficially owned approximately 0.0% of the outstanding common stock as of the close of business on 02/23/2026, and labels the holding as within the 5% or less category.

Does the filing show any shares transferred or sold by the reporting person?

No transfers, purchases, or sales are reported; the filing states the reporting person owned 0 shares as of 02/23/2026 and lists no transactions or holdings to disclose.

BioRestorative (NASDAQ: BRTX) amendment shows no beneficial ownership by filer

SCHEDULE 13G

CUSIP No.

090655606

1

Names of Reporting Persons

Morrison Todd Hale

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

MASSACHUSETTS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.0 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.

(a)

Name of issuer:

BioRestorative Therapies, Inc.

(b)

Address of issuer's principal executive offices:

40 MARCUS DRIVE, 40 MARCUS DRIVE, MELVILLE, NEW YORK, 11747.

Item 2.

(a)

Name of person filing:

Todd Hale Morrison

(b)

Address or principal business office or, if none, residence:

residence

(c)

Citizenship:

United States of America

(d)

Title of class of securities:

Common Stock, $0.0001 par value

(e)

CUSIP No.:

090655606

Item 3.

If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

(b)

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e)

An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f)

An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g)

A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h)

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:

(k)

Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

Item 4.

Ownership

(a)

Amount beneficially owned:

As of the close of business on February 23, 2026, the Reporting Person owned 0 shares of common stock

(b)

Percent of class:

As of the close of business on February 23, 2026, the Reporting Person beneficially owned approximately 0.0% of the outstanding shares of the Issuer's Common Stock

(c)

Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:

0

(ii) Shared power to vote or to direct the vote:

0

(iii) Sole power to dispose or to direct the disposition of:

0

(iv) Shared power to dispose or to direct the disposition of:

0

Item 5.

Ownership of 5 Percent or Less of a Class.

Ownership of 5 percent or less of a class

Item 6.

Ownership of more than 5 Percent on Behalf of Another Person.

Not Applicable

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable

Item 8.

Identification and Classification of Members of the Group.

Not Applicable

Item 9.

Notice of Dissolution of Group.

Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Morrison Todd Hale

Signature:	Todd Hale Morrison
Name/Title:	Individual
Date:	02/23/2026

BioRestorative (NASDAQ: BRTX) amendment shows no beneficial ownership by filer

Rhea-AI Filing Summary

Positive

Negative

FAQ

What does the BRTX Schedule 13G/A amendment report?

Who is the filing person on the BRTX amendment?

What voting and dispositive powers are reported in the filing?

What percentage of BRTX is reported as owned by the filer?

Does the filing show any shares transferred or sold by the reporting person?